444 – RV550: IL-15 Superagonist N-803 With ART in Acute HIV Infection Enhances T and NK Cell Proliferation
Background In the RV550 clinical trial, we hypothesized that IL-15 superagonist N-803 administration with ART during acute HIV infection (AHI) would limit HIV reservoir establishment and persistence. Here, we characterized the effects of N-803 on T cells and NK cells in peripheral blood (PBMC) and lymph nodes (LN). Methods Participants with AHI (Fiebig I-IV) were…